Stay updated on Nivolumab for Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.

Latest updates to the Nivolumab for Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedThe government funding/operating status notice banner was removed from the page, and the study details remain unchanged.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRelated topics Prostate cancer and MedlinePlus Genetics were removed from the page's related resources, reducing navigational options for related information. This change does not affect the core trial content or how to participate.SummaryDifference0.6%

- Check24 days agoChange DetectedThe related topics section now includes Prostate cancer and MedlinePlus Genetics for additional navigation context. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check31 days agoChange DetectedAdded MedlinePlus Genetics topic: Prostate cancer.SummaryDifference0.2%

- Check38 days agoChange Detected- Removed MedlinePlus Genetics topic related to Prostate cancer from the page. This reduces available information on that specific genetic topic.SummaryDifference0.2%

- Check45 days agoChange DetectedSignificant changes: the page now states a funding lapse and current operating status of the NIH Clinical Center, and updates the software version from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to Nivolumab for Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.